High PD-1 expression independent protective factor for PFS. »
08/07/26

NPTXR protein highly and consistently expressed in human tissue samples. »
08/07/26

MSI and MMR IHC results showed strong concordance with molecular findings. »
08/07/26

No dose-limiting toxicity, prolonged myelosuppression, or graft-versus-host disease. »
08/07/26

Transcriptomic analyses of B cells pointed to upregulated antigen-driven stimulation and BCR signaling. »
08/07/26

MCT1 as both metabolic and immunological target. »
08/07/26

SLNB technically equally successful after failed and successful LS. »
08/07/26

Importance of comprehensive genomic characterization of PDX models prior to their use in preclinical studies. »
08/10/26

Trend for improved 1st line PFS in patients diagnosed by screening. »
08/10/26

Classification performance remained high. »
08/10/26